Publication | Closed Access

Determination of ximelagatran, an oral direct thrombin inhibitor, its active metabolite melagatran, and the intermediate metabolites, in biological samples by liquid chromatography–mass spectrometry

Medicinal ChemistryPharmaceutical ScienceLiquid Chromatography–mass SpectrometryBiochemistryMedicineNatural SciencesBioanalysisIntermediate MetabolitesActive Metabolite MelagatranLiquid ChromatographyClinical ChemistryMetabolomicsChromatographic AnalysisPharmacologyChromatographyDrug Analysis